Circulating ghrelin levels in obese women: A possible association with hypertension

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 5, 2007, Pages 568-576

  Oner Iyidogan Y ^a   Kocak H ^a   Gurdol F ^a   Oner P ^a   Issever H ^a   Esin, D ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Blood pressure; Body mass index; Ghrelin; Hypertension; Leptin; Obesity

Indexed keywords

GHRELIN; LEPTIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH HORMONE; HUMANS; HYPERTENSION; LEPTIN; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; POSTMENOPAUSE; TURKEY;

EID: 34548354985     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701210186     Document Type: Article

References (15)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
2. Chanoine JP. Ghrelin in growth and development. Horm Res 2005;63:129-38.
3. Kim MS, Namkoong C, Kim HS, Jang PG, Kim Pak YM, Katakami H, et al. Chronic central administration of ghrelin reverses the effects of leptin. Int J Obes Relat Metab Disord 2004;28:1264-71.
4. Rosicka M, Krsek M, Matoulek M, Jarkovska Z, Marek J, Justova V, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptor levels. Physiol Res 2003;52:61-6.
5. Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001;142:788-94.
6. Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension. New insights into mechanisms. Hypertension 2005;45:9-14.
7. Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 2005;115:911-19.
8. Matsumura K, Tsuchihashi T, Fujii K, Iida M. Neural regulation of blood pressure by leptin and the related peptides. Regul Pept 2003;114:79-86.
9. Sharma V, McNeill JH. The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology. Curr Vasc Pharmacol 2005;3:169-80.
10. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension and the prevalence of type 2 diabetes. Diabetes 2003;52:2546-53.
11. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street? Hypertension 2000;35:807-13.
12. Makino Y, Hosoda H, Shibata K, Makino I, Kojima M, Kangawa K, et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 2002;39:781-4.
13. Akamizu T, Murayama T, Teramukai S, Miura K, Bando I, Irako T, et al. Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure. J Endocrinol 2006;188:333-44.
14. Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005;112:2986-92.
15. Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H, Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002;39:779-83.